Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Accounts Payables (2020 - 2025)

Stemtech's Accounts Payables history spans 6 years, with the latest figure at $5.3 million for Q3 2025.

  • For Q3 2025, Accounts Payables changed N/A year-over-year to $5.3 million; the TTM value through Sep 2025 reached $5.3 million, changed N/A, while the annual FY2024 figure was $4.5 million, 66.8% up from the prior year.
  • Accounts Payables for Q3 2025 was $5.3 million at Stemtech, up from $5.2 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $5.3 million in Q3 2025 and bottomed at $1.4 million in Q3 2022.
  • The 5-year median for Accounts Payables is $3.8 million (2022), against an average of $3.7 million.
  • The largest annual shift saw Accounts Payables tumbled 48.97% in 2022 before it soared 89.3% in 2023.
  • A 5-year view of Accounts Payables shows it stood at $4.1 million in 2021, then fell by 16.15% to $3.4 million in 2022, then dropped by 20.25% to $2.7 million in 2023, then surged by 66.8% to $4.5 million in 2024, then increased by 18.24% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for STEK's Accounts Payables are $5.3 million (Q3 2025), $5.2 million (Q2 2025), and $4.9 million (Q1 2025).